Bibliografía
Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol 1999;43(Suppl):S15–25.
Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from nongynecological malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000;88:358–63.
Chu DZJ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecological malignancy: a prospective study of prognostic factors. Cancer 1989;63:364–7.
Jayne DG, Fook S, Loi S, Seow-Choen F. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002;89: 1545–50.
De Gramont A, Figer A, Seymour M, et al. Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–47.
Lockich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continous infusion fluorouracil with conventional bolus schedule in metastatic colorectal carcinoma. A Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425–32.
Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905–14.
Beaujard AC, Glehen O, Caillot JL, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000;88(11):2512–9.
Piso P, Bektas H, Werner X, et al. Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 2001;27:286–90.
Elias D, Dubé P, Blot F, et al. Peritoneal carcinomatosis treatment with curative intent: the Institute Gustave-Roussy experience. Eur J Surg Oncol 1997;23:317–21.
Shen P, Levine EA, Hall J, et al. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis. Arch Surg 2003; 138:26–33.
Gilly FN, Sayag AC, Carry PY, et al. Chimio-hyperthermie intra-peritoneale (CHIP) dans le traitament des carninoses peritoneales d'órigine digestive. Rapport d'une observation et données physiopathologiques. J Chir (París) 1990;127(2):95–8.
Pestieau SR, Sugarbaker PH, Treatment of primary colon cancer with peritoneal carcinomatosis. Comparison of concomitant vs delayed management. Dis Colon Rectum 2000;43(10):1341–8.
Witkamp AJ, De Bree E, Van Goethem AR, Zoetmulder FAN. Antitumour treatment. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treatment Reviews 2001;27:365–74.
Yonemura Y, Fujimura T, Fushida S, et al. Hypoerthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991;15(4):530–6.
Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbeck's Arch Surg 1999;384:576–87.
Dubé P, Lasser PH, Elias D, Traitement de la carcinose peritoneale d'órigine colorectal. J Chir (Paris) 1997;134 (5–6):233–6.
Maughan TS, James RD, Kerr DJ, et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimen in metastatic colorectal cancer: a multicentre randomised trial. Lancet 2002;359:1555–63.
Spratt JS, Adcock RA, Muskovin M, et al. Clinical de livery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:2563–5.
Elias D, El Otmany A, Bonnay M, et al. Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis. Oncology 2002;63:346–52.
Gomez Portilla A, Sugarbaker PH, Chang D, Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognosis features. World J Surg 1999;23:23–9.
Schneebaum S, Arnold MW, Staubus A, Young DC, Dumond D, Martin EW Jr. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44–50.
Elias D, Blot F, El Otmany A, et al. Curative Treatment of Peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001;92:71–6.
Fujimura T, Yonemura Y, Fujita H, et al. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies. Int Surg 1999;84(1):60–6.
Cavaliere F, Perri P, Di Filippo F, et al. Treatment of peritoneal carcinomatosis with intent of cure. J Surg Oncol 2000;74:41–4.
Witkamp AJ, de Bree E, Kaag MM, Van Slooten GW, Van Coervorden F, Zoetmulder FAN, Extensive surgical cytoreduction and intra-operative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458–63.
Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, Von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585–92.
Zoetmulder FAN, Verwaal V. Hyperthermic intrapoeritoneal chemotherapy (HIPEC) with mitomycin C significantly improves survival in patients with peritoneal carcinomatosis of colorectal origin [abstract]. ASCO Prog Proc 2002;21:147a.
Elias D, Dube P, Bonvalot S, et al. Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate postoperative intraperitoneal chemotherapy: Feasibility and preliminary results. Hepato-Gastroenterol 1999;46:360–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Viguera, J.L. Tratamiento quirúrgico de las metástasis pulmonares. Rev Oncol 6, 362–372 (2004). https://doi.org/10.1007/BF02710068
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02710068